A Revolve Group (RVLV) Co-CEO Sold 16,000 Shares for $414,000 Online fashion retailer Revolve, known for its data-driven e-commerce model, reported a notable insider sale in its latest SEC filing.
Better Long-Term Buy: Berkshire Hathaway or Lemonade? The giant conglomerate and the upstart insurance platform each have their own merits.
As Trump Pushes for "Energy Dominance," 3 Core Energy Holdings Stand Out for Patient Investors A combination of the Trump administration's push to promote domestic energy and geopolitical factors means these three stocks have excellent long-term prospects.
As Trump Leans on Missile Defense in His Iran Strategy, Raytheon Has Never Been More Critical While the war in Iran has generally cooled down in recent days, that doesn't mean RTX stock can't heat up.
Is Palantir Stock Overvalued or Undervalued? The Answer May Surprise You. Value investors won't like this high-profile AI software play, but it's hard to bet against its growth.
An Alignment Healthcare (ALHC) Insider Sold 30,000 Shares for $626,000 This tech-enabled healthcare provider for seniors reported a notable insider sale amid ongoing portfolio management activity.
Which Is the Better Short-Term Bond ETF, iShares' IGSB or Schwab's SCHO? Explore how the underlying bond mix and risk profiles of these ETFs can shape your fixed income strategy in today’s market.
Adaptive Biotechnologies' COO Is Running a Systematic Sell Program — Here's What It Means This immune diagnostics firm reported a notable insider sale as it expands its clinical portfolio and strategic partnerships.
